Tissue Regenix Group announced that Steve Couldwell, its Chief Executive Officer, will be taking a temporary leave of absence from January 2019, predicted to last for first quarter, due to physical ill health in order to undergo medical treatment. The Board has approved interim management changes during the period to ensure effective operational performance and continuity of the Group's strategy. Chairman, John Samuel, will become Executive Chairman and Gareth Jones, currently CFO, will become Chief Operating Officer, both on an interim basis.